ADVFN - Advanced Financial Network.
HOME» NYSE » T » TMO Stock Price » TMO Stock News

Thermo Electron Share News

 Thermo Fisher Scientific Stock Price
TMO Stock Price
 Thermo Fisher Scientific Stock Chart
TMO Stock Chart
 Thermo Fisher Scientific Stock News
TMO Stock News
 Thermo Fisher Scientific Company Information
TMO Company Information
 Thermo Fisher Scientific Stock Trades
TMO Stock Trades

Thermo Fisher to Buy Transplant Diagnostics Test Maker One Lambda for $925 Million

By Saabira Chaudhuri Thermo Fisher Scientific Inc. (TMO) agreed to buy transplant diagnostics test provider One Lambda for $925 million in cash to boost its existing immunosuppressant monitoring assays business. Thermo Fisher, a supplier of analytical technologies and laboratory products, said the purchase price includes the cost of a three-year retention program established for key One Lambda employees, payments payable to certain shareholders for noncompetition agreements and a one-year earn-out provision based on the achievement of certain financial targets. The company said One Lambda generated 2011 revenue of $182 million and will become part of Thermo Fisher's specialty diagnostics segment. "The One Lambda team has pioneered market-leading tests that are widely used across the transplant-testing workflow to improve patient outcomes," Chief Executive Marc N. Casper said. "With its strong technology platform, high margin profile and good growth prospects, the business is perfectly aligned with our specialty in vitro diagnostics strategy." The company expects to close the deal in the fourth quarter and expects it to add nine cents to 11 cents to Thermo Fisher's 2013 adjusted earnings per share. The company also said it expects the deal to generate revenue and cost synergies for a total adjusted operating income benefit of about $15 million in 2015. Thermo Fisher, which in April reported its first-quarter earnings rose 10% on a revenue rise from all segments, has seen strong sales growth over recent quarters, aided by acquisitions and its expansion into Asia-Pacific markets. Last year, the company agreed to buy closely held allergy-testing company Phadia AB for $3.5 billion, and in May it agreed to buy Doe & Ingalls Management LLC for $175 million in cash. Doe & Ingalls provides specialty-production chemicals and related services to the biopharmaceutical and microelectronics industry. Shares closed Friday at $52.04 and were inactive premarket. The stock is down 18% in the last 12 months. Write to Saabira Chaudhuri at

Stock News for Thermo Electron (TMO)
11/30/201517:28:41Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
11/30/201517:24:00Thermo Fisher Scientific Prices Offering of Senior Notes
11/30/201508:54:07Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/24/201506:11:56Securities Registration (section 12(b)) (8-a12b)
11/24/201506:10:55Current Report Filing (8-k)
11/18/201516:08:12Current Report Filing (8-k)
11/17/201506:04:09Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/16/201508:51:35Current Report Filing (8-k)
11/13/201516:08:44Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
11/13/201516:05:00Thermo Fisher Scientific Prices Offering of Euro-Denominated...
11/13/201506:12:27Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/12/201516:30:00Thermo Fisher Scientific Authorizes $1 Billion of Share Repurchases...
11/04/201518:00:00Singapore General Hospital & Thermo Fisher Scientific Collaborate...
11/04/201517:55:05Statement of Changes in Beneficial Ownership (4)
11/03/201517:35:12Statement of Changes in Beneficial Ownership (4)
11/03/201508:30:00Thermo Fisher Scientific to Present at Baird’s 2015 Industrial C...
10/30/201511:08:12Quarterly Report (10-q)
10/28/201516:22:40Initial Statement of Beneficial Ownership (3)
10/21/201506:00:00Thermo Fisher Scientific Reports Third Quarter 2015 Results

Thermo Electron and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations